Eli Lilly and Company
893 S Delaware St
Indianapolis
Indiana
46285
United States
About Eli Lilly and Company
Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.
Karina found her fit at Lilly through our summer internship program. She is now hoping to inspire more Latinx students to make changes in the STEM field just as her mentor did for her. Visit careers.lilly.com/LRL to find open roles in Lilly’s research labs. #WeAreLilly
3430 articles about Eli Lilly and Company
-
Eli Lilly and Company Confirms Date And Conference Call for Third-Quarter 2014 Financial Results Announcement
10/6/2014
-
Lupus Foundation Of America Responds To Eli Lilly and Company's Release Of Data From Clinical Trial Of Tabalumab
10/2/2014
-
Eli Lilly and Company's Seventh Global Day Of Service Rallies 24,000 Employees In Nearly 60 Countries
9/29/2014
-
Eli Lilly and Company Gets Thumbs Up From FDA For Diabetes Drug Trulicity
9/22/2014
-
Eli Lilly and Company Release: CYRAMZA™ In Combination With Paclitaxel Significantly Improves Overall Survival In Second-Line Gastric Cancer Patients
9/18/2014
-
Eli Lilly Bets $500 Million On AstraZeneca PLC’s Alzheimer's Drug
9/17/2014
-
Denovo Biopharma Acquires Late-Stage Oncology Drug From Eli Lilly and Company For Development As A Personalized Medicine
9/17/2014
-
Working Mother Names Eli Lilly and Company To Its 100 Best Companies List For 20 Years
9/16/2014
-
Eli Lilly and Company's Cyramza Met Primary Endpoint In Phase 3 Study
9/12/2014
-
Eli Lilly and Company Highlights Latest Work In Diabetes Discovery And Development At 2014 European Association For The Study Of Diabetes Annual Meeting
9/9/2014
-
Diabetes: Boehringer Ingelheim Corporation And Eli Lilly and Company Announce Data On Portfolio To Be Presented At The 50th EASD Annual Meeting
9/9/2014
-
Eli Lilly and Company's Diabetes Drug Trumps Sanofi's In Phase 3 Trials
9/5/2014
-
Voyager Pharmaceutical Corporation Taps Ex-Eli Lilly and Company Exec For CEO Post
9/3/2014
-
Eli Lilly and Company, Takeda Pharmaceutical Co. Ltd. Lose Bid To Overturn $9 Billion Award For Hiding Actos' Cancer Risk
8/29/2014
-
Eli Lilly and Company Release: New Type 2 Diabetes Treatment Jardiance® (empagliflozin) Tablets For Adults Now Available In U.S. Pharmacies
8/26/2014
-
Eli Lilly and Company To Participate In Morgan Stanley 2014 Global Healthcare Conference
8/25/2014
-
Eli Lilly and Company's Psoriasis Drug Ixekizumab Succeeds In Late-Stage Studies
8/21/2014
-
FDA Tentatively Approves Boehringer Ingelheim Corporation, Eli Lilly and Company's Basaglar™
8/19/2014
-
Eli Lilly and Company-Tied Church Sues Chase Over Mismanaged Trust
8/19/2014
-
Eli Lilly To Shutter Animal Enzyme Plant
8/15/2014